Sulfamethoxazole, Trimethoprim

• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending
  2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
• Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending
  2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• Efficacy and safety of circumcision alone on risk of febrile urinary tract infections in boys with posterior urethral valves: a prospective … Pending
  2024-519166-48-01 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
• A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending
  2024-519504-27-00 Phase III 10 countries Regeneron Pharmaceuticals Inc.
• Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin… Pending
  2025-523922-42-00 Phase IV 1 country Consorci Mar Parc De Salut De Barcelona
• LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending
  2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
• A Phase 1/2 study of ALXN2350 in adult participants with BAG3-associated dilated cardiomyopathy Recruiting
  2024-519674-40-00 Phase I (FiH) 3 countries Alexion Pharmaceuticals Inc.
• Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting
  2025-524484-20-00 Phase IV 1 country UZ Leuven
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting
  2024-514312-27-00 Phase IV 1 country Rigshospitalet
• Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting
  2024-514900-16-00 Phase IV 1 country Region Hovedstaden
• A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting
  2024-514398-23-00 Phase I/II 1 country Charite Universitaetsmedizin Berlin KöR
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• First-line combination of Bcl-2 inhibitor and monoclonal antibody followed by administration of Bcl-2 inhibitor alone or combination of Bcl-… Recruiting
  2023-510431-11-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting
  2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
• Alternative antibiotics to multidrug-resistant UTIs Recruiting
  2024-513294-41-00 Phase IV 1 country Region Skane
• Pharmacokinetics of antibiotics in cerebrospinal fluid of children with malignant brain tumors – a pilot study Recruiting
  2024-518808-43-00 Phase I 1 country Medical University Of Vienna
• A Phase 3 Study of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in AdultsUndergoin… Ended
  2024-514471-18-00 Phase III 5 countries Mundipharma Research Limited

Showing 1–19 of 19 trials